Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial

BACKGROUND: There is currently no standard prognostic model optimized for the patients with diffuse large B-cell lymphoma (DLBCL) treated with upfront intensive immunochemotherapy including autologous stem cell transplantation (ASCT). The Kyoto Prognostic Index (KPI) has been proposed as a novel pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Tsutomu, Yamamoto, Kazuhito, Kagami, Yoshitoyo, Machida, Ryunosuke, Miyazaki, Kana, Nakamura, Shigeo, Kuroda, Junya, Maruyama, Dai, Nagai, Hirokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157300/
https://www.ncbi.nlm.nih.gov/pubmed/35353186
http://dx.doi.org/10.1093/jjco/hyac039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157300/
https://www.ncbi.nlm.nih.gov/pubmed/35353186
http://dx.doi.org/10.1093/jjco/hyac039

Ejemplares similares